These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26966023)

  • 1. Meta-analysis of executive functioning in ecstasy/polydrug users.
    Roberts CA; Jones A; Montgomery C
    Psychol Med; 2016 Jun; 46(8):1581-96. PubMed ID: 26966023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-reports of executive dysfunction in current ecstasy/polydrug Users.
    Hadjiefthyvoulou F; Fisk JE; Montgomery C; Bridges N
    Cogn Behav Neurol; 2012 Sep; 25(3):128-38. PubMed ID: 22960437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical oxygenation suggests increased effort during cognitive inhibition in ecstasy polydrug users.
    Roberts CA; Montgomery C
    J Psychopharmacol; 2015 Nov; 29(11):1170-81. PubMed ID: 26333432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. fNIRS suggests increased effort during executive access in ecstasy polydrug users.
    Roberts CA; Montgomery C
    Psychopharmacology (Berl); 2015 May; 232(9):1571-82. PubMed ID: 25391436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological indices of response inhibition in human polydrug users.
    Roberts CA; Fairclough S; Fisk JE; Tames FT; Montgomery C
    J Psychopharmacol; 2013 Sep; 27(9):779-89. PubMed ID: 23803689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory.
    Montgomery C; Fisk JE; Newcombe R; Murphy PN
    Psychopharmacology (Berl); 2005 Oct; 182(2):262-76. PubMed ID: 16010539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in prefrontal blood oxygenation during an acute multitasking stressor in ecstasy polydrug users.
    Roberts CA; Wetherell MA; Fisk JE; Montgomery C
    Psychol Med; 2015 Jan; 45(2):395-406. PubMed ID: 25066866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological evidence of atypical processing underlying mental set shifting in ecstasy polydrug and polydrug users.
    Roberts CA; Fairclough SH; McGlone FP; Fisk JE; Montgomery C
    Exp Clin Psychopharmacol; 2013 Dec; 21(6):507-15. PubMed ID: 24080019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Reay JL; Hamilton C; Kennedy DO; Scholey AB
    J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERP evidence suggests executive dysfunction in ecstasy polydrug users.
    Roberts CA; Fairclough SH; Fisk JE; Tames F; Montgomery C
    Psychopharmacology (Berl); 2013 Aug; 228(3):375-88. PubMed ID: 23532375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updating of working memory in ecstasy polydrug users: Findings from fNIRS.
    Montgomery C; Fisk JE; Roberts CA
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28631348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of polymorphism at the serotonin transporter gene on decision-making, memory and executive function in ecstasy users and controls.
    Roiser JP; Rogers RD; Cook LJ; Sahakian BJ
    Psychopharmacology (Berl); 2006 Oct; 188(2):213-27. PubMed ID: 16941121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfunctional overnight memory consolidation in ecstasy users.
    Smithies V; Broadbear J; Verdejo-Garcia A; Conduit R
    J Psychopharmacol; 2014 Aug; 28(8):751-62. PubMed ID: 24595967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Soar K; Parrott A; Turner J
    J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic ecstasy (MDMA) use is associated with deficits in task-switching but not inhibition or memory updating executive functions.
    Dafters RI
    Drug Alcohol Depend; 2006 Jun; 83(2):181-4. PubMed ID: 16316723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
    Gouzoulis-Mayfrank E; Thimm B; Rezk M; Hensen G; Daumann J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the functional significance of ecstasy-related memory deficits using a virtual paradigm.
    Montgomery C; Hatton NP; Fisk JE; Ogden RS; Jansari A
    Hum Psychopharmacol; 2010; 25(4):318-25. PubMed ID: 20521322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.